OrganiGram Holdings Inc. (TSX:OGI) (NASDAQ:OGI) has received Health Canada approval on 17 cultivation rooms, but OrganiGram stock is down 2.6%.
The licenses, which are valid until March 2020, will increase the company’s yield by approximately 15,000 kilograms per annum and brings its Moncton-based facility to a target operational capacity of 76,000 kilograms. These 17 newly licensed cultivation rooms are the first in the company’s Phase 4B expansion to receive approval. OrganiGram stock is currently valued at $4.81, having rebounded over 20% last week.
“Once again, we are pleased to receive licensing approval consistent with ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.